We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of New Prenatal Diagnostic Tests From Maternal Blood

This study has been terminated.
(Leaving of the person responsible for the data collection)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00314691
First Posted: April 14, 2006
Last Update Posted: July 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Strasbourg, France
April 12, 2006
April 14, 2006
July 28, 2011
April 2006
Not Provided
Feasibility of fetal gender and genotype determination out of maternal blood
Feasability of fetal gender and genotype determination out of maternal blood
Complete list of historical versions of study NCT00314691 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Development of New Prenatal Diagnostic Tests From Maternal Blood
Development of New Prenatal Diagnostic Tests From Maternal Blood
After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Hereditary Diseases
Genetic: Blood samples
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
10
September 2006
Not Provided

Inclusion Criteria:

  • Mother and father-to-be both older than 18 years old
  • Mother and father-to-be affiliated to social security
  • Mother and father-to-be have good understanding of the protocol
  • Pregnancy of the mother-to-be attested

Exclusion Criteria:

  • Mother and father-to-be are younger than 18 years old
  • Mother and/or father-to be refusing to participate
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00314691
3612
Not Provided
Not Provided
Not Provided
Not Provided
University Hospital, Strasbourg, France
Not Provided
Principal Investigator: Romain FAVRE, MD SIHCUS-CMCO de Schiltigheim, Strasbourg, FRANCE
University Hospital, Strasbourg, France
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP